COVID-19 and CSRC: Drug Guidance Resources

Below is a list of resources compiled by CSRC members to guide you on cardiac safety, drug development, and its relation to COVID-19. Click on the hyperlinks below to access journal articles and other academic materials.

Cardiovascular Risk Management

CV Risk of compounds been used to treat COVID-19 (Hydroxychloroquine, Chloroquine, Azithromycin)

DDIs

Selected clinical study reports of CV risk in COVID-19 patients

Online tools to understand QT-prolongation risk and optimize drug prescription